AU2001256582A1 - Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine - Google Patents
Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccineInfo
- Publication number
- AU2001256582A1 AU2001256582A1 AU2001256582A AU5658201A AU2001256582A1 AU 2001256582 A1 AU2001256582 A1 AU 2001256582A1 AU 2001256582 A AU2001256582 A AU 2001256582A AU 5658201 A AU5658201 A AU 5658201A AU 2001256582 A1 AU2001256582 A1 AU 2001256582A1
- Authority
- AU
- Australia
- Prior art keywords
- virus
- prrsv
- recombinant
- orf
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20665500P | 2000-05-24 | 2000-05-24 | |
US60206655 | 2000-05-24 | ||
PCT/IB2001/000870 WO2001089559A2 (en) | 2000-05-24 | 2001-05-18 | Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001256582A1 true AU2001256582A1 (en) | 2001-12-03 |
Family
ID=22767352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001256582A Abandoned AU2001256582A1 (en) | 2000-05-24 | 2001-05-18 | Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
Country Status (12)
Country | Link |
---|---|
US (1) | US20030003112A1 (zh) |
EP (1) | EP1283718A2 (zh) |
JP (1) | JP2003533989A (zh) |
KR (1) | KR20030036194A (zh) |
CN (1) | CN1443076A (zh) |
AU (1) | AU2001256582A1 (zh) |
BR (1) | BR0111366A (zh) |
CA (1) | CA2409874A1 (zh) |
MX (1) | MXPA02011545A (zh) |
PL (1) | PL360096A1 (zh) |
WO (1) | WO2001089559A2 (zh) |
ZA (1) | ZA200210230B (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7628980B2 (en) | 2000-11-23 | 2009-12-08 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
DK1335987T4 (en) | 2000-11-23 | 2016-09-19 | Bavarian Nordic As | Modified variant of vaccinia virus Ankara |
US7445924B2 (en) | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
SK11282003A3 (sk) * | 2001-03-09 | 2004-02-03 | Boehringer Ingelheim Vetmedica Gmbh | Oslabený európsky PRRS vírus, nukleotidová sekvencia kódujúca vírus, spôsob generovania infekčného živého oslabeného PRRS vírusu, bunková línia a farmaceutický prostriedok s jeho obsahom a jeho použitie |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7276353B2 (en) * | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
EP2204179A3 (en) | 2002-04-19 | 2010-12-22 | Bavarian Nordic A/S | Modified Vaccinia Virus Ankara for the vaccination of neonates |
MXPA04012966A (es) | 2002-09-05 | 2005-05-16 | Bavarian Nordic As | Metodo para el cultivo de celulas primarias y para la amplificacion de virus bajo condiciones libres de suero. |
ATE403005T1 (de) * | 2003-02-18 | 2008-08-15 | Helmholtz Zentrum Muenchen | Rekombinantes mva und verfahren zur erzeugung davon |
JP2005075752A (ja) * | 2003-08-29 | 2005-03-24 | Nippon Inst For Biological Science | 豚繁殖・呼吸障害症候群用ワクチン製剤 |
US7761863B2 (en) * | 2004-06-08 | 2010-07-20 | Covia Labs, Inc. | Method system and data structure for content renditioning adaptation and interoperability segmentation model |
DK1773387T3 (da) * | 2004-06-25 | 2013-07-15 | Merial Ltd | Avipox-rekombinanter der udtrykker mund- og klovesyge-virusgener |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US8398994B2 (en) * | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
EP1792996A1 (en) * | 2005-12-01 | 2007-06-06 | Consejo Superior de Investigaciones Cientificas | Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
BRPI0812124A2 (pt) * | 2007-05-30 | 2014-10-14 | Wyeth Llc | Poxviridae de guaxinim expressando genes de vírus suíno |
CL2008001806A1 (es) * | 2007-06-20 | 2008-09-05 | Wyeth Corp | Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion. |
EP2200643B1 (en) | 2007-09-17 | 2013-09-04 | Boehringer Ingelheim Vetmedica, Inc. | A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs |
KR101420850B1 (ko) * | 2011-05-30 | 2014-08-13 | 건국대학교 산학협력단 | 돼지 생식기 호흡기 증후군 바이러스 유사입자 및 이를 이용한 백신 |
EP2714077B1 (en) * | 2011-06-01 | 2018-02-28 | Merial, Inc. | Needle-free administration of prrsv vaccines |
CN106574260A (zh) * | 2014-08-08 | 2017-04-19 | 出光兴产株式会社 | 猪繁殖与呼吸障碍综合征防治剂 |
DE102015111756A1 (de) | 2015-07-20 | 2017-01-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Rekombinanter Orf-Virus-Vektor |
CN107236824A (zh) * | 2017-06-29 | 2017-10-10 | 新希望六和股份有限公司 | 一种用于猪繁殖与呼吸综合征病毒特异性检测的荧光定量rt‑pcr试剂盒及应用 |
US20230241074A1 (en) * | 2020-05-29 | 2023-08-03 | University Of Connecticut | Inhibitors of porcine reproductive and respiratory syndrome virus |
CN116333060B (zh) * | 2023-05-15 | 2023-07-21 | 广州悦洋生物技术有限公司 | 猪繁殖与呼吸综合征病毒gp5蛋白及其制备方法和用途、基因、试剂盒和检测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE247163T1 (de) * | 1991-03-07 | 2003-08-15 | Virogenetics Corp | Gentechnologisch hergestellter stamm für impfstoffe |
DK53595A (da) * | 1994-05-13 | 1995-11-14 | Iberica Cyanamid | Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner |
JPH11507241A (ja) * | 1995-06-07 | 1999-06-29 | シントロ・コーポレーション | 組換え鶏痘ウイルスおよびその使用 |
FR2775601B1 (fr) * | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
-
2001
- 2001-05-18 MX MXPA02011545A patent/MXPA02011545A/es unknown
- 2001-05-18 WO PCT/IB2001/000870 patent/WO2001089559A2/en not_active Application Discontinuation
- 2001-05-18 PL PL36009601A patent/PL360096A1/xx not_active Application Discontinuation
- 2001-05-18 CA CA002409874A patent/CA2409874A1/en not_active Abandoned
- 2001-05-18 JP JP2001585802A patent/JP2003533989A/ja not_active Withdrawn
- 2001-05-18 KR KR1020027015977A patent/KR20030036194A/ko not_active Application Discontinuation
- 2001-05-18 EP EP01929903A patent/EP1283718A2/en not_active Withdrawn
- 2001-05-18 AU AU2001256582A patent/AU2001256582A1/en not_active Abandoned
- 2001-05-18 CN CN01813156A patent/CN1443076A/zh active Pending
- 2001-05-18 BR BR0111366-6A patent/BR0111366A/pt not_active Application Discontinuation
- 2001-05-21 US US09/862,393 patent/US20030003112A1/en not_active Abandoned
-
2002
- 2002-12-18 ZA ZA200210230A patent/ZA200210230B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001089559A3 (en) | 2002-04-11 |
BR0111366A (pt) | 2003-05-20 |
CA2409874A1 (en) | 2001-11-29 |
WO2001089559A2 (en) | 2001-11-29 |
ZA200210230B (en) | 2003-10-27 |
JP2003533989A (ja) | 2003-11-18 |
US20030003112A1 (en) | 2003-01-02 |
KR20030036194A (ko) | 2003-05-09 |
EP1283718A2 (en) | 2003-02-19 |
CN1443076A (zh) | 2003-09-17 |
PL360096A1 (en) | 2004-09-06 |
MXPA02011545A (es) | 2003-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030003112A1 (en) | Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant poxvirus vaccine | |
CA2167080C (en) | Prrsv recombinant proteins, diagnostic kits and vaccines containing prrs recombinant proteins | |
Urniza et al. | Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 proteins in protection | |
EP1283887B1 (en) | Chimeric arterivirus-like particles | |
US20110117129A1 (en) | Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS) | |
WO2006074986A2 (en) | Prrs vaccines | |
KR102664662B1 (ko) | 돼지 파보바이러스 및 돼지 생식기 및 호흡기 증후군 바이러스에 대한 백신 및 이의 제조 방법 | |
JP7129978B2 (ja) | 豚繁殖・呼吸障害症候群(prrs)ウイルスの欧州株に対抗する離乳前の効果的なワクチン接種 | |
CA2599322A1 (en) | N protein mutants of porcine reproductive and respiratory syndrome virus | |
JP2004534522A (ja) | 生きた弱毒化されたprrsウイルス株 | |
US20180236056A1 (en) | Needle-free administration of PRRSV vaccines | |
WO2008153572A1 (en) | Construction of chimera prrsv, compositions and vaccine preparations | |
Pineyro Pineiro | Novel approaches towards vaccine developments against porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus | |
EP1469076A2 (en) | Recombinant PRRS proteins, diagnostic kits and vaccines containing said recombinant proteins | |
Zhang et al. | CELL SURFACE EXPRESSION OF VIRAL PROTEINS OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS IN INSECT CELLS AND THEIR ROLE IN PROTECTION AGAINST RESPIRATORY DISEASE | |
Hocker | Evaluation of protection provided by inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines | |
AU2002256653A1 (en) | Life attenuated strains of PRRS virus |